Eli Lilly and Company (LLY) gained 6.52% on October 30, 2026, pushing the stock's price to $1,373. The single-session advance extended a broader trend of gains for the pharmaceutical giant, whose shares have risen 5.07% over the past seven days.
Over the trailing 30-day period, LLY has climbed 15.74%, reflecting sustained buying pressure across a longer timeframe. The company's market capitalization stood at $1,148.34 billion as of the close of trading.
The combination of daily, weekly, and monthly gains places Eli Lilly among the more active large-cap movers in the market. With a market capitalization exceeding $1 trillion, the company remains one of the largest publicly traded pharmaceutical firms by valuation.
The stock's performance across all three measured timeframes — one day, seven days, and thirty days — has trended positive, underscoring the consistency of the price appreciation recorded through the end of October 2026.
